Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Moderna, Inc.MRNA · Entity 2025 | Chief Financial Officer | October 05, 2026 | October 07, 2026 |
| REVVITY, INC.PKI · Entity 3382 | Please See Remarks | June 24, 2022 | June 27, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Moderna, Inc.
Report date October 05, 2026 · Filed October 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 60,125 |
Ending reported balance
After 2026-10-05 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-10-05 · Exercise / conversion · Acquired 1,454 · Balance 60,829 F1: Restricted stock units convert into common stock on a one-for-one basis. Row 2 · 2026-10-05 · Tax withholding · Disposed 704 · Balance 60,125 F2: Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-10-05 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-10-05 · Exercise / conversion · Disposed 1,454 · Balance 0 F1: Restricted stock units convert into common stock on a one-for-one basis. F3: 25% of the shares subject to this restricted stock unit award vested on October 5, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units convert into common stock on a one-for-one basis.
F2: Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units.
F3: 25% of the shares subject to this restricted stock unit award vested on October 5, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
REVVITY, INC.
Report date June 24, 2022 · Filed June 27, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 27,577 |
Ending reported balance
After 2022-06-24 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2022-06-24 · Sale · Disposed 2,072 · Balance 30,530 F1: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by Mr. Mock on May 23, 2022. F2: The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $144.27 to $145.11. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. Row 2 · 2022-06-24 · Sale · Disposed 2,290 · Balance 28,240 F1: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by Mr. Mock on May 23, 2022. F3: The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $145.27 to $146.26. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. Row 3 · 2022-06-24 · Sale · Disposed 663 · Balance 27,577 F1: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by Mr. Mock on May 23, 2022. F4: The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $146.28 to $146.40. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by Mr. Mock on May 23, 2022.
F2: The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $144.27 to $145.11. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
F3: The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $145.27 to $146.26. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
F4: The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $146.28 to $146.40. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 27, 2026 Filed Mar 3, 2026 21:04 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionCommon Stock | 329 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001682852-26-000038 · form4.xml · nonDerivative · entry 1 Mock James M · CIK 0001736359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,553 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 21:41 UTC | Moderna, Inc. MRNA · Entity 2025 | Tax withholdingCommon Stock | 1,278 | $41.99 | $53,663.22 |
DisclosureSEC source: 0001682852-26-000024 · form4.xml · nonDerivative · entry 2 Mock James M · CIK 0001736359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,224 F2 · kind: Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vesting of the 2023 PSUs. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 21:41 UTC | Moderna, Inc. MRNA · Entity 2025 | GrantCommon Stock | 2,630 | $0.00 | $0.00 |
DisclosureSEC source: 0001682852-26-000024 · form4.xml · nonDerivative · entry 1 Mock James M · CIK 0001736359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,502 F1 · kind: The reported transaction is the vesting of performance-based restricted stock units granted to the reporting person on February 28, 2023 (the "2023 PSUs"). Read SEC document |
| January 05, 2026 Filed Jan 6, 2026 21:36 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionRestricted Stock Units · Derivative | 1,452 | $0.00 | $0.00 |
DisclosureSEC source: 0001682852-26-000005 · form4.xml · derivative · entry 3 Mock James M · CIK 0001736359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,359 Underlying: Common Stock · 1,452 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: 25% of the shares subject to this restricted stock unit award vested on October 5, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter. F3 · derivative.expiration_date: 25% of the shares subject to this restricted stock unit award vested on October 5, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter. Read SEC document |
| January 05, 2026 Filed Jan 6, 2026 21:36 UTC | Moderna, Inc. MRNA · Entity 2025 | Tax withholdingCommon Stock | 780 | $30.86 | $24,070.80 |
DisclosureSEC source: 0001682852-26-000005 · form4.xml · nonDerivative · entry 2 Mock James M · CIK 0001736359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,872 F2 · kind: Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. Read SEC document |
| January 05, 2026 Filed Jan 6, 2026 21:36 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionCommon Stock | 1,452 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001682852-26-000005 · form4.xml · nonDerivative · entry 1 Mock James M · CIK 0001736359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,652 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 05, 2025 Filed Dec 8, 2025 21:44 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionRestricted Stock Units · Derivative | 47,190 | $0.00 | $0.00 |
DisclosureSEC source: 0001682852-25-000090 · form4.xml · derivative · entry 3 Mock James M · CIK 0001736359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,571 Underlying: Common Stock · 47,190 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: 25% of the shares subject to this restricted stock unit award vested on December 5, 2025, with the remainder vesting in twelve (12) equal quarterly installments thereafter. F3 · derivative.expiration_date: 25% of the shares subject to this restricted stock unit award vested on December 5, 2025, with the remainder vesting in twelve (12) equal quarterly installments thereafter. Read SEC document |
| December 05, 2025 Filed Dec 8, 2025 21:44 UTC | Moderna, Inc. MRNA · Entity 2025 | Tax withholdingCommon Stock | 22,817 | $25.49 | $581,605.33 |
DisclosureSEC source: 0001682852-25-000090 · form4.xml · nonDerivative · entry 2 Mock James M · CIK 0001736359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,200 F2 · kind: Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. Read SEC document |
| December 05, 2025 Filed Dec 8, 2025 21:44 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionCommon Stock | 47,190 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001682852-25-000090 · form4.xml · nonDerivative · entry 1 Mock James M · CIK 0001736359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,017 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| November 28, 2025 Filed Dec 1, 2025 21:27 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionRestricted Stock Units · Derivative | 329 | $0.00 | $0.00 |
DisclosureSEC source: 0001682852-25-000082 · form4.xml · derivative · entry 6 Mock James M · CIK 0001736359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,644 Underlying: Common Stock · 329 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter. F4 · derivative.expiration_date: 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter. Read SEC document |
| November 28, 2025 Filed Dec 1, 2025 21:27 UTC | Moderna, Inc. MRNA · Entity 2025 | Tax withholdingCommon Stock | 160 | $25.01 | $4,001.60 |
DisclosureSEC source: 0001682852-25-000082 · form4.xml · nonDerivative · entry 4 Mock James M · CIK 0001736359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,827 F2 · kind: Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. Read SEC document |
| November 28, 2025 Filed Dec 1, 2025 21:27 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionCommon Stock | 329 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001682852-25-000082 · form4.xml · nonDerivative · entry 3 Mock James M · CIK 0001736359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,987 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| November 26, 2025 Filed Dec 1, 2025 21:27 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionRestricted Stock Units · Derivative | 773 | $0.00 | $0.00 |
DisclosureSEC source: 0001682852-25-000082 · form4.xml · derivative · entry 5 Mock James M · CIK 0001736359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,963 Underlying: Common Stock · 773 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter. F3 · derivative.expiration_date: 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter. Read SEC document |
| November 26, 2025 Filed Dec 1, 2025 21:27 UTC | Moderna, Inc. MRNA · Entity 2025 | Tax withholdingCommon Stock | 374 | $24.75 | $9,256.50 |
DisclosureSEC source: 0001682852-25-000082 · form4.xml · nonDerivative · entry 2 Mock James M · CIK 0001736359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,658 F2 · kind: Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. Read SEC document |
| November 26, 2025 Filed Dec 1, 2025 21:27 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionCommon Stock | 773 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001682852-25-000082 · form4.xml · nonDerivative · entry 1 Mock James M · CIK 0001736359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,032 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| October 03, 2025 Filed Oct 6, 2025 20:23 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionRestricted Stock Units · Derivative | 1,453 | $0.00 | $0.00 |
DisclosureSEC source: 0001682852-25-000059 · form4.xml · derivative · entry 3 Mock James M · CIK 0001736359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,811 Underlying: Common Stock · 1,453 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: 25% of the shares subject to this restricted stock unit award vested on October 5, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter. F3 · derivative.expiration_date: 25% of the shares subject to this restricted stock unit award vested on October 5, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter. Read SEC document |
| October 03, 2025 Filed Oct 6, 2025 20:23 UTC | Moderna, Inc. MRNA · Entity 2025 | Tax withholdingCommon Stock | 703 | $28.37 | $19,944.11 |
DisclosureSEC source: 0001682852-25-000059 · form4.xml · nonDerivative · entry 2 Mock James M · CIK 0001736359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,259 F2 · kind: Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. Read SEC document |
| October 03, 2025 Filed Oct 6, 2025 20:23 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionCommon Stock | 1,453 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001682852-25-000059 · form4.xml · nonDerivative · entry 1 Mock James M · CIK 0001736359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,962 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| August 28, 2025 Filed Aug 29, 2025 20:13 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionRestricted Stock Units · Derivative | 329 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-021032 · form4.xml · derivative · entry 6 Mock James M · CIK 0001736359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,973 Underlying: Common Stock · 329 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter. F4 · derivative.expiration_date: 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter. Read SEC document |
| August 28, 2025 Filed Aug 29, 2025 20:13 UTC | Moderna, Inc. MRNA · Entity 2025 | Tax withholdingCommon Stock | 160 | $25.10 | $4,016.00 |
DisclosureSEC source: 0001127602-25-021032 · form4.xml · nonDerivative · entry 4 Mock James M · CIK 0001736359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,509 F2 · kind: Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. Read SEC document |
| August 28, 2025 Filed Aug 29, 2025 20:13 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionCommon Stock | 329 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-021032 · form4.xml · nonDerivative · entry 3 Mock James M · CIK 0001736359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,669 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| August 27, 2025 Filed Aug 29, 2025 20:13 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionRestricted Stock Units · Derivative | 774 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-021032 · form4.xml · derivative · entry 5 Mock James M · CIK 0001736359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,736 Underlying: Common Stock · 774 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter. F3 · derivative.expiration_date: 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter. Read SEC document |
| August 27, 2025 Filed Aug 29, 2025 20:13 UTC | Moderna, Inc. MRNA · Entity 2025 | Tax withholdingCommon Stock | 375 | $24.73 | $9,273.75 |
DisclosureSEC source: 0001127602-25-021032 · form4.xml · nonDerivative · entry 2 Mock James M · CIK 0001736359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,340 F2 · kind: Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. Read SEC document |
| August 27, 2025 Filed Aug 29, 2025 20:13 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionCommon Stock | 774 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-021032 · form4.xml · nonDerivative · entry 1 Mock James M · CIK 0001736359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,715 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| July 03, 2025 Filed Jul 7, 2025 20:59 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionRestricted Stock Units · Derivative | 1,453 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-018989 · form4.xml · derivative · entry 3 Mock James M · CIK 0001736359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,264 Underlying: Common Stock · 1,453 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: 25% of the shares subject to this restricted stock unit award vested on October 5, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter. F3 · derivative.expiration_date: 25% of the shares subject to this restricted stock unit award vested on October 5, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter. Read SEC document |
| July 03, 2025 Filed Jul 7, 2025 20:59 UTC | Moderna, Inc. MRNA · Entity 2025 | Tax withholdingCommon Stock | 703 | $30.28 | $21,286.84 |
DisclosureSEC source: 0001127602-25-018989 · form4.xml · nonDerivative · entry 2 Mock James M · CIK 0001736359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,941 F2 · kind: Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. Read SEC document |
| July 03, 2025 Filed Jul 7, 2025 20:59 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionCommon Stock | 1,453 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-018989 · form4.xml · nonDerivative · entry 1 Mock James M · CIK 0001736359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,644 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| May 28, 2025 Filed May 29, 2025 21:16 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionRestricted Stock Units · Derivative | 328 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-015911 · form4.xml · derivative · entry 6 Mock James M · CIK 0001736359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,302 Underlying: Common Stock · 328 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter. F4 · derivative.expiration_date: 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter. Read SEC document |
| May 28, 2025 Filed May 29, 2025 21:16 UTC | Moderna, Inc. MRNA · Entity 2025 | Tax withholdingCommon Stock | 159 | $26.76 | $4,254.84 |
DisclosureSEC source: 0001127602-25-015911 · form4.xml · nonDerivative · entry 4 Mock James M · CIK 0001736359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,191 F2 · kind: Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. Read SEC document |
| May 28, 2025 Filed May 29, 2025 21:16 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionCommon Stock | 328 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-015911 · form4.xml · nonDerivative · entry 3 Mock James M · CIK 0001736359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,350 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| May 27, 2025 Filed May 29, 2025 21:16 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionRestricted Stock Units · Derivative | 773 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-015911 · form4.xml · derivative · entry 5 Mock James M · CIK 0001736359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,510 Underlying: Common Stock · 773 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter. F3 · derivative.expiration_date: 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter. Read SEC document |
| May 27, 2025 Filed May 29, 2025 21:16 UTC | Moderna, Inc. MRNA · Entity 2025 | Tax withholdingCommon Stock | 374 | $26.26 | $9,821.24 |
DisclosureSEC source: 0001127602-25-015911 · form4.xml · nonDerivative · entry 2 Mock James M · CIK 0001736359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,022 F2 · kind: Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. Read SEC document |
| May 27, 2025 Filed May 29, 2025 21:16 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionCommon Stock | 773 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-015911 · form4.xml · nonDerivative · entry 1 Mock James M · CIK 0001736359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,396 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| April 04, 2025 Filed Apr 7, 2025 20:18 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionRestricted Stock Units · Derivative | 1,452 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-011760 · form4.xml · derivative · entry 3 Mock James M · CIK 0001736359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,717 Underlying: Common Stock · 1,452 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: 25% of the shares subject to this restricted stock unit award vested on October 5, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter. F3 · derivative.expiration_date: 25% of the shares subject to this restricted stock unit award vested on October 5, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter. Read SEC document |
| April 04, 2025 Filed Apr 7, 2025 20:18 UTC | Moderna, Inc. MRNA · Entity 2025 | Tax withholdingCommon Stock | 703 | $25.73 | $18,088.19 |
DisclosureSEC source: 0001127602-25-011760 · form4.xml · nonDerivative · entry 2 Mock James M · CIK 0001736359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,623 F2 · kind: Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of performance stock stock units. Read SEC document |
| April 04, 2025 Filed Apr 7, 2025 20:18 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionCommon Stock | 1,452 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-011760 · form4.xml · nonDerivative · entry 1 Mock James M · CIK 0001736359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,326 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| March 01, 2025 Filed Mar 3, 2025 21:49 UTC | Moderna, Inc. MRNA · Entity 2025 | GrantRestricted Stock Units · Derivative | 39,606 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-007550 · form4.xml · derivative · entry 5 Mock James M · CIK 0001736359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,606 Underlying: Common Stock · 39,606 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F5 · derivative.exercise_date: 25% of the shares subject to this restricted stock unit award will vest on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter. F5 · derivative.expiration_date: 25% of the shares subject to this restricted stock unit award will vest on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter. Read SEC document |
| March 01, 2025 Filed Mar 3, 2025 21:49 UTC | Moderna, Inc. MRNA · Entity 2025 | GrantStock Option (Right to Buy) · Derivative | 63,478 | $0.00 Strike: $30.96 | $0.00 |
DisclosureSEC source: 0001127602-25-007550 · form4.xml · derivative · entry 4 Mock James M · CIK 0001736359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,478 Underlying: Common Stock · 63,478 shares Expires 2035-03-01 F4 · derivative.exercise_date: 25% of this option will vest and become exercisable on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:49 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionRestricted Stock Units · Derivative | 329 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-007550 · form4.xml · derivative · entry 3 Mock James M · CIK 0001736359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,630 Underlying: Common Stock · 329 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter. F3 · derivative.expiration_date: 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:49 UTC | Moderna, Inc. MRNA · Entity 2025 | Tax withholdingCommon Stock | 160 | $31.09 | $4,974.40 |
DisclosureSEC source: 0001127602-25-007550 · form4.xml · nonDerivative · entry 2 Mock James M · CIK 0001736359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,874 F2 · kind: Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:49 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionCommon Stock | 329 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-007550 · form4.xml · nonDerivative · entry 1 Mock James M · CIK 0001736359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,034 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 27, 2025 Filed Feb 28, 2025 21:30 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionRestricted Stock Units · Derivative | 1,326 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-007277 · form4.xml · derivative · entry 9 Mock James M · CIK 0001736359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,326 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F3 · kind: Restricted stock units convert into common stock on a one-for-one basis. F7 · derivative.exercise_date: 25% of the shares subject to this restricted stock unit award vested on May 27, 2024 with the remainder vesting in three (3) equal quarterly installments thereafter. F7 · derivative.expiration_date: 25% of the shares subject to this restricted stock unit award vested on May 27, 2024 with the remainder vesting in three (3) equal quarterly installments thereafter. Read SEC document |
| February 27, 2025 Filed Feb 28, 2025 21:30 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionRestricted Stock Units · Derivative | 3,094 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-007277 · form4.xml · derivative · entry 8 Mock James M · CIK 0001736359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,283 Underlying: Common Stock · 3,094 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F3 · kind: Restricted stock units convert into common stock on a one-for-one basis. F6 · derivative.exercise_date: 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter. F6 · derivative.expiration_date: 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter. Read SEC document |
| February 27, 2025 Filed Feb 28, 2025 21:30 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionPerformance Stock Units · Derivative | 1,326 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-007277 · form4.xml · derivative · entry 7 Mock James M · CIK 0001736359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,326 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units convert into common stock on a one-for-one basis. F1 · kind: Performance stock units convert into common stock on a one-for-one basis. F5 · derivative.exercise_date: 25% of the shares subject to this performance stock unit award vested on May 31, 2024 upon determination of achievement of the performance criteria, with the remainder vesting in three (3) equal installments on August 27, 2024, November 27, 2024 and February 27, 2025. F5 · derivative.expiration_date: 25% of the shares subject to this performance stock unit award vested on May 31, 2024 upon determination of achievement of the performance criteria, with the remainder vesting in three (3) equal installments on August 27, 2024, November 27, 2024 and February 27, 2025. Read SEC document |
| February 27, 2025 Filed Feb 28, 2025 21:30 UTC | Moderna, Inc. MRNA · Entity 2025 | Tax withholdingCommon Stock | 642 | $33.58 | $21,558.36 |
DisclosureSEC source: 0001127602-25-007277 · form4.xml · nonDerivative · entry 6 Mock James M · CIK 0001736359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,705 F4 · kind: Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. Read SEC document |
| February 27, 2025 Filed Feb 28, 2025 21:30 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionCommon Stock | 1,326 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-007277 · form4.xml · nonDerivative · entry 5 Mock James M · CIK 0001736359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,347 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: Restricted stock units convert into common stock on a one-for-one basis. F3 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 27, 2025 Filed Feb 28, 2025 21:30 UTC | Moderna, Inc. MRNA · Entity 2025 | Tax withholdingCommon Stock | 1,496 | $33.58 | $50,235.68 |
DisclosureSEC source: 0001127602-25-007277 · form4.xml · nonDerivative · entry 4 Mock James M · CIK 0001736359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,021 F4 · kind: Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. Read SEC document |
| February 27, 2025 Filed Feb 28, 2025 21:30 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionCommon Stock | 3,094 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-007277 · form4.xml · nonDerivative · entry 3 Mock James M · CIK 0001736359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,517 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: Restricted stock units convert into common stock on a one-for-one basis. F3 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 27, 2025 Filed Feb 28, 2025 21:30 UTC | Moderna, Inc. MRNA · Entity 2025 | Tax withholdingCommon Stock | 642 | $33.58 | $21,558.36 |
DisclosureSEC source: 0001127602-25-007277 · form4.xml · nonDerivative · entry 2 Mock James M · CIK 0001736359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,423 F2 · kind: Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of performance stock stock units. Read SEC document |
| February 27, 2025 Filed Feb 28, 2025 21:30 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionCommon Stock | 1,326 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-007277 · form4.xml · nonDerivative · entry 1 Mock James M · CIK 0001736359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,065 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Performance stock units convert into common stock on a one-for-one basis. F1 · price: Performance stock units convert into common stock on a one-for-one basis. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.